Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases FENTORA ®...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases 2005 12/28/2005...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases 2006 12/19/2006...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases 2007 12/31/2007...
Cephalon - Media Resource Center
Background Documents Multimedia Files Prescribing Information Press Releases AMRIX Fact Sheet Muscle Spasm Fact Sheet AMRIX photo (.jpg) FENTORA ® Press Kit FENTORA is the first and only buccal (membrane on the inside of the cheek) tablet indicated for the management of breakthrough pain in opioid-tolerant patients with cancer, and the first tablet...
Cephalon - Pipeline
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Cephalon Science Preclinical Research Clinical Research R&D; Collaboration Pipeline Pipeline Promise for today, hope for tomorrow. Name Clinical Development Status FENTORA ® (fentanyl buccal tablet)[C-II]...
Cephalon - Clinical Trials Results
Terms of Use | Privacy _uacct = "UA-1207593-1"; urchinTracker(); Cephalon - Clinical Trials Results Cephalon - Clinical Trials Results Cephalon, Clinical trials, Clinical studies, Clinical research, FENTORA, Fentanyl buccal tablet, OraVescent, Pivotal trials, Lestaurtinib, Acute myeloid leukemia, AML, FLT3, PROVIGIL, Modafinil, NUVIGIL, SPARLON, Attention deficit...
Cephalon - Clinical Trials Recruiting
Terms of Use | Privacy _uacct = "UA-1207593-1"; urchinTracker(); Cephalon - Clinical Trials Recruiting Cephalon - Clinical Trials Recruiting Cephalon, Clinical trials, Clinical studies, Clinical research, FENTORA, Fentanyl buccal tablet, OraVescent, Pivotal trials, Lestaurtinib, Acute myeloid leukemia, AML, FLT3, PROVIGIL, Modafinil, NUVIGIL, SPARLON, Attention deficit...
Cephalon - Products Overview
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Products State Compliance - International Operations Drug Delivery Technologies Products Innovative treatments for central nervous system disorders, pain, cancer and addiction Cephalon has eight proprietary products in the...
Breakthrough Pain Patient Profile Ruthie
Ruthie Atlanta, Georgia Ovarian cancer survivor with breakthrough pain In 2001, Ruthie received devastating news; she had ovarian cancer. Ruthie reported the pain to her oncologist who prescribed various short- acting opioids (strong pain medicines that start working in about 30 to 40 minutes and usually last about two to six hours). The unpredictable onset of the pain also had...
author: jrdiebol
Breakthrough Pain Patient Profile Ruthie page 2
author: jrdiebol
Breakthrough Pain Patient Profile Lonna
Lonna Ontario, California Melanoma and lung cancer survivor with breakthrough pain Twenty years ago, Lonna was diagnosed and successfully treated for melanoma but in 1989, she learned that the cancer had spread to her lungs. Long- acting opioids brought relief for her persistent pain; however, the short- acting opioids prescribed for breakthrough pain did not result in...
author: jrdiebol
Breakthrough Pain Patient Profile Lonna page 2
author: jrdiebol
TRISENOX Fact Sheet
TRI 091 April 2007 TRISENOX Fact Sheet p. Of the approximately 13,500 patients diagnosed with AML in the United States every year, 10- 15 percent will have the APL subtype, according to the National Cancer Institute. 2 of 4 The most common adverse events in the pivotal clinical trial (n= 40) were generally manageable, reversible, and usually did not require interruption of...
author: jantonac
TRISENOX Fact Sheet page 3
author: jantonac
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases VIVITROL® 05...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases TRISENOX® 07...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases TREANDA® 02/19...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases PROVIGIL® 09...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases NUVIGIL™ 06...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases GABITRIL® 06...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases ACTIQ® 02/01...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases AMRIX® 02/14...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases 2001 12/28/2001...
Cephalon - News Releases
Home | Contact Us | Cephalon Sites | Site Index | - SEARCH Our Business Products Cephalon Science Patients and Physicians Investor Information Newsroom Careers - Newsroom News Releases By Year: 2008 2007 2006 2005 2004 2003 2002 2001 By Product: AMRIX ACTIQ FENTORA GABITRIL NUVIGIL PROVIGIL TREANDA TRISENOX VIVITROL Media Resources On The Record News Releases 2002 12/23/2002...